Tumor microenvironment–responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy
Frontiers in Pharmacology · 03.01.2025 · 15
DOI: 10.3389/fphar.2024.1518983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 03.01.2025. Verfasst von Qi Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The characteristics of the tumor microenvironment (TME) have a close and internal correlation with the effect of cancer immunotherapy, significantly affecting the progression and metastasis of cancer. The rational design of nanoenzymes that possess the ability to respond to and regulate the TME is driving a new direction in catalytic immunotherapy. In this study, we designed a multifunctional manganese (Mn)-based nanoenzyme that is responsive to acidic pH and overxpressed H 2 O 2 at tumor site and holds capability of modulating hypoxic and immunosuppressive TME for synergistic anti-tumor photothermal/photodynamic/immunotherapy. We found that this artificial nanoenzyme promoted peroxidase-like and catalase-like activities and catalyzed the in-situ decomposition of H 2 O 2 , a metabolic waste product in the TME, into ∙OH and O 2 , resulting in a ROS burst for killing tumors and relieving hypoxic TME to enhance cancer therapy. Besides the photothermal effect and the enhancement of ROS burst-induced immunogenic cell death, combination of Mn 2+ released from Mn-based nanoenzyme in acidic TME and programmed death-ligand 1 blockade triggered a significant anti-tumor immune response. A remarkable in vivo synergistic therapeutic effect was achieved with effective inhibition of primary tumor growth and lung metastasis. Therefore, this TME-responsive Mn-based nanoenzyme offers a safe and efficient platform for reversing the immunosuppressive microenvironment and achieving synergistic anti-tumor immunotherapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- Key Laboratory of Pathobiology, Ministry of Education, Nanomedicine and Translational Research Center, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- Key Laboratory of Pathobiology Ministry of Education, Department of Anatomy, College of Basic Medical Sciences, Jilin University, Changchun, China.
- Department of Pathology, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
- Department of General Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin, China.
Zitieren
APA
Yang, Q., Wu, Q., Liu, H., Wu, J., Ma, F., & Tian, X. (2025). Tumor microenvironment–responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1518983
Vancouver
Yang Q, Wu Q, Liu H, Wu J, Ma F, Tian X. Tumor microenvironment–responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy. Frontiers in Pharmacology. 2025;15. doi:10.3389/fphar.2024.1518983
BibTeX
@article{Yang2025,
author = {Yang, Qi and Wu, Qiong and Liu, Haiyan and Wu, Jiandong and Ma, Feng and Tian, Xiaofeng},
title = {Tumor microenvironment–responsive and modulatory manganese-based nanoenzyme for enhanced tumor immunotherapy},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {15},
doi = {10.3389/fphar.2024.1518983}
}
EUVIMED